Anaplastic Lymphoma Kinase Expression and Prognosis in Inflammatory Myofibroblastic Tumours of the Maxillary Sinus

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.6, 2009-11, pp. : 2000-2008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Clinical and Immunohistochemical Features, Including Anaplastic Lymphoma Kinase (ALK) and p53, in Inflammatory Myofibroblastic Tumours

By Jiang You-Hua Cheng Bo Ge Ming-Hua Cheng Ye Zhang Gu

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 867-877

Field House Publishing

Access to resources Recommend Favorite

Inhibitors of the anaplastic lymphoma kinase

By Mologni Luca

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 985-994

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase as a therapeutic target

By Kruczynski Anna Delsol Georges Laurent Camille Brousset Pierre Lamant Laurence

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1127-1138

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of anaplastic lymphoma kinase: a patent review

By Milkiewicz Karen L Ott Gregory R

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1653-1681

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy

By Coluccia AML Gunby RH Tartari CJ Scapozza L Gambacorti-Passerini C Passoni Lorena

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 515-532

Informa Healthcare

Access to resources Recommend Favorite